According to @binance, Christian Angermayer, Founder of Apeiron, will speak at Binance Blockchain Week with stated themes of blockchain, biotech, and the future of investment; source: Binance on X, Nov 30, 2025. For traders, the agenda highlights cross-industry applications, making it practical to track event outputs aligned with these themes to refine watchlists and narrative-driven setups during the conference; source: Binance on X, Nov 30, 2025.

According to Paolo Ardoino, Atai Life Sciences and Christian Angermayer have made a strategic decision to incorporate Bitcoin into their balance sheet. This move is seen as a reinforcement of the company's financial fundamentals. By holding Bitcoin, the company aims to leverage its potential as a store of value and hedge against inflation, which is relevant for trading strategies and long-term financial planning (source: @paoloardoino).